Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vinod S Ramgolam

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Endocrine, Metabolic & Immune Disorders Drug Targets|April 14, 2010
Interferon-beta inhibits Th17 cell differentiation in patients with multiple sclerosisVinod S Ramgolam, Silva Markovic-Plese
Journal of Signal Transduction|December 2, 2011
Regulation of suppressors of cytokine signaling as a therapeutic approach in autoimmune diseases, with an emphasis on multiple sclerosisVinod S Ramgolam, Silva Markovic-Plese
Journal of Leukocyte Biology|July 12, 2005
Cytokines and cardiovascular diseaseVishal C Mehra, Vinod S Ramgolam, Jeffrey R Bender
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytesXin Zhang, Jianping Jin, Xueyan Peng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 29, 2009
IFN-beta inhibits human Th17 cell differentiationVinod S Ramgolam, Yonggang Sha, Jianping Jin, et al.
Frontiers in Pharmacology|January 28, 2026
X-inactive specific transcript (XIST) can determine sex differences in cardiovascular drug responses: focus on RNA therapeuticsTimur O Yarovinsky, Vinod S Ramgolam, Iva R Knezevic, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 4, 2011
B cells as a therapeutic target for IFN-β in relapsing-remitting multiple sclerosisVinod S Ramgolam, Yonggang Sha, Karen L Marcus, et al.
Plos One|January 6, 2011
T cell LFA-1 engagement induces HuR-dependent cytokine mRNA stabilization through a Vav-1, Rac1/2, p38MAPK and MKK3 signaling cascadeVinod S Ramgolam, Scott D DeGregorio, Gautham K Rao, et al.
Plos One|July 27, 2018
T cell LFA-1-induced proinflammatory mRNA stabilization is mediated by the p38 pathway kinase MK2 in a process regulated by hnRNPs C, H1 and KGautham K Rao, Albert Wong, Mark Collinge, et al.
Iscience|December 4, 2023
Distinct hypoxia-induced translational profiles of embryonic and adult-derived macrophagesNicholas S Wilcox, Timur O Yarovinsky, Prakruti Pandya, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Endocrine, Metabolic & Immune Disorders Drug Targets|April 14, 2010
Interferon-beta inhibits Th17 cell differentiation in patients with multiple sclerosisVinod S Ramgolam, Silva Markovic-Plese
Journal of Signal Transduction|December 2, 2011
Regulation of suppressors of cytokine signaling as a therapeutic approach in autoimmune diseases, with an emphasis on multiple sclerosisVinod S Ramgolam, Silva Markovic-Plese
Journal of Leukocyte Biology|July 12, 2005
Cytokines and cardiovascular diseaseVishal C Mehra, Vinod S Ramgolam, Jeffrey R Bender
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytesXin Zhang, Jianping Jin, Xueyan Peng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 29, 2009
IFN-beta inhibits human Th17 cell differentiationVinod S Ramgolam, Yonggang Sha, Jianping Jin, et al.
Frontiers in Pharmacology|January 28, 2026
X-inactive specific transcript (XIST) can determine sex differences in cardiovascular drug responses: focus on RNA therapeuticsTimur O Yarovinsky, Vinod S Ramgolam, Iva R Knezevic, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 4, 2011
B cells as a therapeutic target for IFN-β in relapsing-remitting multiple sclerosisVinod S Ramgolam, Yonggang Sha, Karen L Marcus, et al.
Plos One|January 6, 2011
T cell LFA-1 engagement induces HuR-dependent cytokine mRNA stabilization through a Vav-1, Rac1/2, p38MAPK and MKK3 signaling cascadeVinod S Ramgolam, Scott D DeGregorio, Gautham K Rao, et al.
Plos One|July 27, 2018
T cell LFA-1-induced proinflammatory mRNA stabilization is mediated by the p38 pathway kinase MK2 in a process regulated by hnRNPs C, H1 and KGautham K Rao, Albert Wong, Mark Collinge, et al.
Iscience|December 4, 2023
Distinct hypoxia-induced translational profiles of embryonic and adult-derived macrophagesNicholas S Wilcox, Timur O Yarovinsky, Prakruti Pandya, et al.
Pageof 2